Continuing a trend of firms focusing on minute body systems, a company called EBT has raised $10 million for "pelvic health". Apparently they use neuromodulation to calm an overactive bladder. I would like to announce that I am starting a new company and would happily take even $5 million in financing for it. I have noticed that people often have problems in the webby spaces between their toes and fingers. So I am starting a digital web health company. Notice I already have two of the necessary buzz words in there. I also intend to be disruptive and I will use analytics and big data and I am sure machines can learn something about this and any intelligence applied to the area will definitely be artificial. Send checks or Paypal, Applepay, whatever, as soon as possible. I guarantee the same return you will get from investing in other companies with similar descriptions of their business.
Rightway Healthcare secures $20 million in new capital for, once again, some gibberish relating to a service that I can't understand, but apparently has something to do with helping the patient on their journey through the health system.
Wellframe offers yet another digital health platform, one that does the usual of allowing patients and providers to share data and set goals, etc. The Company has booked a new infusion of $20 million in funding.
Medical genetic testing management company Invitae invites Clear Genetics to become part of the family, acquiring the maker of a chatbot to help consumers navigate genetic testing, for about $50 million.
EHR vendor NextGen has acquired Medfusion for $43 million. Medfusion offers a "patient experience" platform. Investors might have to be patient to experience a return.
Apervita, which offers software to help hospitals with quality measures and programs, becomes a warm-up before meal treat for investors, who serve up a fresh $22 million in financing.
Medopad, which does something related to gathering health information from wearables, pads its bank account with $25 in new capital, apparently raised at a valuation of around $200 million. There is too much capital and when there is, it does stupid stuff.
In a short-lived announcement, Human Longevity births a fresh $30 million in capital to support the company's business of combining information to help assess individual's health, etc.
Twistle, a provider of automation for communication and care management processes, whistles up a fresh $16 million in funding. Oh, and did I mention that it is "disruptive".
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.